AZ-1355

CAS: 75451-07-9

Ref. 3D-ADA45107

Produktinformation

• Name: AZ-1355
• Marke: Biosynth
• Beschreibung: AZ-1355 is a novel, orally bioavailable, small molecule inhibitor of collagen-specific proteinase (MMP-1) that has been shown to be effective in preventing the development of cerebral amyloidosis in hamsters. AZ-1355 is orally bioavailable and penetrates the blood brain barrier, thus reducing the amount of MMP-1 that can enter the brain. This drug has also been shown to reduce cardiac collagen deposition and improve endothelial function. AZ-1355 has not been tested on humans or animals for its potential toxicity, but it does have a toxic profile in vitro. This drug has also been shown to have damaging effects on platelets and cause death in cultured cells.

Chemische Eigenschaften

• Molekulargewicht: 299.32 g/mol
• Formel: C₁₇H₁₇NO₄
• Reinheit: Min. 95%